Healthcare entity
regulation is the sole category represented across all 1 tracked stories. RMC-6236 is most often covered alongside ERAS-0015, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention RMC-6236, all published on June 16, 2026.
Last mentioned: Jul 7, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. RMC-6236 is most often covered alongside ERAS-0015, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention RMC-6236, all published on June 16, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering RMC-6236. Shared-story counts are live from our verified record — not editorial picks.
Following a patient death in its ERAS-0015 trial, Erasca faces allegations it withheld risks, leading to a 48% stock collapse. The case underscores threats to clinical transparency.
RMC-6236 is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
